Foracort Junior Inhaler is a combination medication containing Formoterol (6mcg) and Budesonide (100mcg) designed for the management of asthma in pediatric patients. Formoterol is a long-acting beta2-adrenergic agonist that helps relax the muscles in the airways, improving breathing by preventing bronchospasm. Budesonide is an inhaled corticosteroid that reduces inflammation and swelling in the airways, thereby decreasing the frequency and severity of asthma attacks. This dual-action inhaler provides both immediate bronchodilation and long-term control of airway inflammation, making it effective for maintenance therapy in children with persistent asthma. Foracort Junior is typically prescribed for regular use to maintain open airways and prevent symptoms such as wheezing, coughing, and shortness of breath. It is important to use the inhaler exactly as directed by a healthcare professional, and not to exceed the recommended dose. Common side effects may include throat irritation, hoarseness, or oral thrush, which can be minimized by rinsing the mouth after use. Foracort Junior Inhaler is a valuable treatment option that helps improve lung function and quality of life for children with asthma when used consistently as part of a comprehensive asthma management plan.